Construction and identification of recombinant adenoviral shuttle vector with radiation-inducible TRAIL gene

Journal of Jilin University Medicine Edition

Volumn 34, Issue 3, 2008, Pages 364-368

  Li, Yan Bo ^a   Liang, Shuo ^a   Dong, Li Hua ^a   Yang, Wei ^a   Guo, Cai Xia ^a   Sun, Li Guang ^a   Gong, Shou Liang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Adenovirus; Cloning; Egr 1; Molecular; Radiation; TRAIL

Indexed keywords

ADENOVIRUS VECTOR; EARLY GROWTH RESPONSE FACTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENE VECTOR; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RADIOSENSITIVITY; RECOMBINANT GENE; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHUTTLE VECTOR; VIRAL GENE DELIVERY SYSTEM;

EID: 46249091856     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells [J]. Cancer Res, 1994, 54 (16). 4266-4269.
2. Weichselbaum RR, Hallahan DE, Sukhatme VP, et al. Gene therapy targeting by ionizing radiation [J]. Int J Radiat Oncol Biol Phys, 1992, 24 (3): 565-567.
3. Hallahan DE, Mauceri HJ, Seung LP, et al. Spatial and temporal control of gene therapy using ionizing radiation [J]. Nat Med, 1995, 1 (8): 786-791.
4. Hsu H, Rainov NG, Quinones A, et al. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter [J]. Anticancer Res, 2003, 23 (3B): 2723-2728.
5. Weichselbaum RR, Kufe DW, Hellman S, et al. Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy [J]. Lancet Oncol, 2002, 3 (11): 665-671.
6. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of new membe of the TNF family that induces apoptosis [J]. Immunity, 1995, 3 (6): 673-682.
7. Wissink EH, Verbrugge I, Vink SR, et al. TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy [J]. Radiother Oncol, 2006, 80 (2): 214-222.
8. Baierlein SA, Distel L, Sieber R, et al. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells [J]. Strahlenther Onkol, 2006, 182 (8): 467-472.
9. Tsurushima H, Yuan X, Dillehay LE, et al. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors [J]. Cancer Gene Ther, 2007, 14 (8): 706-716.
10. Matsubara H, Mizutani Y, Hongo F, et al. Gene therapy with TRAIL against renal cell carcinoma [J]. Mol Cancer Ther, 2006, 5 (9): 2165-2171.
11. Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene [J]. Cancer Res, 2001, 61 (8): 3330-3338.